A detailed history of Core Cap Advisors, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 12 shares of FLGT stock, worth $214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$214
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$19.6 - $25.06 $235 - $300
12 New
12 $0
Q2 2022

Aug 11, 2022

BUY
$47.98 - $62.75 $7,868 - $10,291
164 New
164 $9,000
Q1 2022

Apr 29, 2022

SELL
$49.85 - $96.11 $13,160 - $25,373
-264 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$77.3 - $105.0 $20,407 - $27,720
264 New
264 $27,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.